Xarelto 20 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26F5G1Q
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $31,609
Award facts
- Contract value 100% obligated
- $31,608.54 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On February 4, 2026, the Defense Logistics Agency awarded a delivery order valued at $31,608.54 to AmerisourceBergen Drug Corp for the supply of Xarelto 20 mg tablets in a 90-count configuration. This firm fixed-price contract is non-set-aside and represents a competitive award under the company's broader pharmaceutical supply relationship with the federal government. The order will be fulfilled from AmerisourceBergen's operations in Conshohocken, Pennsylvania, with an ultimate completion date of February 5, 2026. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), a major pharmaceutical distributor serving as a critical vendor for federal medical procurement.
This delivery order is executed under Cencora's significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2031, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally. The IDC encompasses a comprehensive range of medications across multiple therapeutic domains, including specialty drugs, brand-name and generic pharmaceuticals, and related medical supplies. Xarelto, an anticoagulant medication commonly prescribed for stroke prevention and blood clot treatment, represents one of the diverse pharmaceutical products supplied through this contract vehicle to support the Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F5G1Q?
SPE2DR26F5G1Q was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26F5G1Q worth?
The government has obligated $31,609 on SPE2DR26F5G1Q.
Is contract SPE2DR26F5G1Q an order under another contract?
Yes. SPE2DR26F5G1Q is a delivery order under SPE2DR25D3306, an indefinite delivery contract.
Was contract SPE2DR26F5G1Q competed?
The extent of competition for SPE2DR26F5G1Q was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award